review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.3109/23744235.2016.1164890 |
P698 | PubMed publication ID | 27207312 |
P50 | author | Asha Mary Abraham | Q61092417 |
P2093 | author name string | Shoba David | |
P2860 | cites work | West Nile virus ecology in a tropical ecosystem in Guatemala | Q36522972 |
West Nile virus neurologic disease in humans, South Africa, September 2008-may 2009. | Q36570560 | ||
Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders | Q40558466 | ||
Vitritis and chorioretinitis in a patient with West Nile virus infection | Q40565503 | ||
Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City | Q40572754 | ||
Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. | Q40596353 | ||
Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells | Q40615405 | ||
The pathology of human West Nile Virus infection. | Q40620671 | ||
West Nile virus in Pakistan. 1. Sero-epidemiological studies in Punjab Province | Q40848413 | ||
Fatal human case of West Nile disease, Mexico, 2009. | Q42553238 | ||
West Nile virus infection, Assam, India | Q42553644 | ||
Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. | Q42988629 | ||
Genetic analysis of West Nile New York 1999 encephalitis virus | Q42996823 | ||
Prevalence of antibodies to Japanese encephalitis and West Nile viruses among wild birds in the Krishna-Godavari Delta, Andhra Pradesh, India | Q43034361 | ||
West Nile virus infection transmitted by granulocyte transfusion | Q43037151 | ||
West Nile virus in the blood donors in UAE. | Q43047404 | ||
West Nile virus | Q56932479 | ||
Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing | Q24537549 | ||
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey | Q24570061 | ||
Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases | Q24570064 | ||
Virus and antibody dynamics in acute west nile virus infection | Q24570066 | ||
Flavivirus genome organization, expression, and replication | Q24575500 | ||
Clinical characteristics of the West Nile fever outbreak, Israel, 2000 | Q24644796 | ||
Migratory birds and spread of West Nile virus in the Western Hemisphere | Q24653883 | ||
Rab 5 is required for the cellular entry of dengue and West Nile viruses | Q24683001 | ||
High-throughput detection of West Nile virus RNA | Q24727669 | ||
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion | Q24736810 | ||
A single siRNA suppresses fatal encephalitis induced by two different flaviviruses | Q25255046 | ||
West Nile virus: review of the literature | Q26827766 | ||
Flavivirus cell entry and membrane fusion | Q26852458 | ||
Experimental infections of wild birds with West Nile virus | Q27010636 | ||
West Nile virus infection and its neurological manifestations | Q27469441 | ||
Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells | Q27469442 | ||
Nonviremic transmission of West Nile virus | Q27469992 | ||
Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival | Q27472671 | ||
NS1 protein secretion during the acute phase of West Nile virus infection | Q27472703 | ||
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus | Q27472711 | ||
Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus | Q27472775 | ||
West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection | Q27472821 | ||
Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic | Q27473031 | ||
A Single Amino Acid Substitution in the West Nile Virus Nonstructural Protein NS2A Disables Its Ability To Inhibit Alpha/Beta Interferon Induction and Attenuates Virus Virulence in Mice | Q27473041 | ||
Structures of immature flavivirus particles | Q27477478 | ||
Molecular and Functional Analyses of Kunjin Virus Infectious cDNA Clones Demonstrate the Essential Roles for NS2A in Virus Assembly and for a Nonconservative Residue in NS3 in RNA Replication | Q27477562 | ||
Crystal Structure of the West Nile Virus Envelope Glycoprotein | Q27477648 | ||
Acute anterior radiculitis associated with West Nile virus infection | Q27477869 | ||
Performance of a Commercial Immunoglobulin M Antibody Capture Assay Using Analyte-Specific Reagents To Screen for Interfering Factors during a West Nile Virus Epidemic Season in Nebraska | Q27478067 | ||
Virus Detection Protocols for West Nile Virus in Vertebrate and Mosquito Specimens | Q27478077 | ||
Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion | Q27481089 | ||
Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis | Q27481332 | ||
ICAM-1 Participates in the Entry of West Nile Virus into the Central Nervous System | Q27485744 | ||
Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization | Q27485890 | ||
Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis | Q27486589 | ||
Matrix Metalloproteinase 9 Facilitates West Nile Virus Entry into the Brain | Q27486919 | ||
Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005 | Q27487086 | ||
West Nile Virus in Birds, Argentina | Q27487095 | ||
Importation of West Nile Virus Infection from Nicaragua to Spain | Q27487489 | ||
Morphologic and Molecular Characterization of New Cyclospora Species from Ethiopian Monkeys: C. cercopitheci sp.n., C. colobi sp.n., and C. papionis sp.n | Q27487726 | ||
Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999 | Q27487787 | ||
Mosquito Surveillance for West Nile Virus in Connecticut, 2000: Isolation fromCulex pipiens,Cx. restuans,Cx. salinarius, andCuliseta melanura | Q27487796 | ||
West Nile Fever Outbreak, Israel, 2000: Epidemiologic Aspects | Q27487819 | ||
West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier | Q27488411 | ||
West Nile Virus, Venezuela | Q27489161 | ||
Phylogenetic Relationships of Southern African West Nile Virus Isolates | Q27489408 | ||
Progress on the development of therapeutics against West Nile virus | Q27489893 | ||
West Nile Virus from Blood Donors, Vertebrates, and Mosquitoes, Puerto Rico, 2007 | Q27490886 | ||
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States | Q27860919 | ||
The global ecology and epidemiology of West Nile virus | Q28083311 | ||
West Nile virus meningoencephalitis | Q28260103 | ||
Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor | Q28289980 | ||
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis | Q29615108 | ||
Experimental infection of North American birds with the New York 1999 strain of West Nile virus | Q29616255 | ||
West Nile encephalitis epidemic in southeastern Romania | Q29620822 | ||
West Nile virus: a primer for the clinician | Q29620970 | ||
West Nile virus infection: a new acute paralytic illness | Q30809985 | ||
West nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review | Q30882541 | ||
Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features | Q30952283 | ||
In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein | Q33877316 | ||
Guillain-Barré syndrome: An unusual presentation of West Nile virus infection | Q33909229 | ||
West Nile virus: recent trends in diagnosis and vaccine development | Q36733137 | ||
Complete genome sequence of west nile virus isolated from alappuzha district, kerala, India | Q36850055 | ||
The continuing spread of West Nile virus in the western hemisphere | Q36945748 | ||
PROCLEIX West Nile virus assay based on transcription-mediated amplification | Q37206142 | ||
Genome sequencing of West Nile Virus from human cases in Greece, 2012. | Q37235321 | ||
The complex epidemiological scenario of West Nile virus in Italy | Q37295897 | ||
Large human outbreak of West Nile virus infection in north-eastern Italy in 2012 | Q37376390 | ||
Integrated human surveillance systems of West Nile virus infections in Italy: the 2012 experience | Q37434935 | ||
Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway | Q37511523 | ||
Clinical manifestations and outcomes of West Nile virus infection | Q37611824 | ||
A review of the epidemiological and clinical aspects of West Nile virus | Q37708659 | ||
Acute flaccid paralysis due to West nile virus infection in adults: A paradigm shift entity | Q37712155 | ||
Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex | Q38008644 | ||
Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features | Q38211715 | ||
SYBR green-based real-time quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability | Q38342670 | ||
Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin | Q38396005 | ||
Genome-wide real-time PCR for West Nile virus reduces the false-negative rate and facilitates new strain discovery. | Q38656483 | ||
Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009. | Q38889460 | ||
Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of West Nile virus | Q39338373 | ||
West Nile encephalitis outbreak in Kerala, India, 2011. | Q40201608 | ||
Excretion of West Nile virus in urine during acute infection | Q40242372 | ||
Experimental and natural vertical transmission of West Nile virus by California Culex (Diptera: Culicidae) mosquitoes | Q40252837 | ||
Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria | Q40260718 | ||
West nile virus infection in Xinjiang, China | Q40262153 | ||
Serological evidence of West Nile virus infection in wild migratory and resident water birds in Eastern and Northern India | Q40276360 | ||
Molecular detection and characterization of West Nile virus associated with multifocal retinitis in patients from southern India | Q40305306 | ||
Neutralising antibodies for West Nile virus in horses from Brazilian Pantanal | Q40319092 | ||
Detection of antibodies to West Nile virus in horses, Costa Rica, 2004. | Q40330500 | ||
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas | Q40340633 | ||
Evaluation of efficacy and human health risk of aerial ultra-low volume applications of pyrethrins and piperonyl butoxide for adult mosquito management in response to West Nile virus activity in Sacramento County, California | Q40361009 | ||
West Nile virus seroprevalence in blood donors from Central Anatolia, Turkey | Q40371169 | ||
Seroprevalence of west nile virus in ghana | Q40397435 | ||
Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay | Q40412314 | ||
A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse | Q40423412 | ||
Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity | Q40424421 | ||
Immunochemical and single molecule force spectroscopy studies of specific interaction between the laminin binding protein and the West Nile virus surface glycoprotein E domain II. | Q40432699 | ||
A multiplexed TaqMan assay for the detection of arthropod-borne flaviviruses | Q40446603 | ||
West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. | Q40449765 | ||
West Nile virus isolates from India: evidence for a distinct genetic lineage. | Q40456848 | ||
Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. | Q40474846 | ||
Nucleic acid testing for west nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. | Q40481213 | ||
West Nile virus among blood donors in the United States, 2003 and 2004. | Q40502172 | ||
Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models | Q40505199 | ||
Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells | Q40505862 | ||
Use of RNA interference to prevent lethal murine west nile virus infection | Q40513711 | ||
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases | Q40514804 | ||
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase | Q40517134 | ||
West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death | Q40540197 | ||
Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 | Q40550030 | ||
West Nile virus infection presenting as cerebellar ataxia and fever: case report | Q40551521 | ||
Neurologic manifestations and outcome of West Nile virus infection | Q33967282 | ||
Isolation of West Nile virus in Israel | Q33968689 | ||
West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas | Q33976242 | ||
A seroprevalence study of west nile virus infection in solid organ transplant recipients | Q33982270 | ||
Acute Arboviral Infections in Guinea, West Africa, 2006 | Q34024894 | ||
Arboviruses associated with human disease in Australia | Q34117466 | ||
Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults | Q34154300 | ||
Transmission of West Nile virus from an organ donor to four transplant recipients | Q34201110 | ||
Serological investigations of flavivirus prevalence in Khammouane Province, Lao People's Democratic Republic, 2007-2008. | Q34240192 | ||
Epidemiology of West Nile disease in Europe and in the Mediterranean Basin from 2009 to 2013 | Q34270985 | ||
Intensive early season adulticide applications decrease arbovirus transmission throughout the Coachella Valley, Riverside County, California | Q34298842 | ||
Characterization of Rabensburg virus, a flavivirus closely related to West Nile virus of the Japanese encephalitis antigenic group | Q34314429 | ||
Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. | Q34315016 | ||
Clinical characteristics and functional outcomes of West Nile Fever | Q34346420 | ||
Punctate exanthem of West Nile Virus infection: report of 3 cases | Q34364715 | ||
CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. | Q34480246 | ||
Control of arbovirus infections by a coordinated response: West Nile Virus in England and Wales | Q34575722 | ||
West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety | Q34718025 | ||
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial | Q34833926 | ||
The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis | Q35211686 | ||
West nile virus (Kunjin subtype) disease in the northern territory of Australia--a case of encephalitis and review of all reported cases | Q35494632 | ||
Serologic diagnosis of West Nile virus infection | Q35589295 | ||
Emergence of human West Nile Virus infection in Sri Lanka | Q35727740 | ||
West Nile Virus in horses, sub-Saharan Africa | Q35793538 | ||
West Nile virus population genetics and evolution | Q35826344 | ||
West Nile Virus isolation in human and mosquitoes, Mexico | Q35847424 | ||
West Nile virus detection in urine | Q35873354 | ||
Genetic characterization of West Nile virus lineage 2, Greece, 2010. | Q35876730 | ||
Putative new lineage of west nile virus, Spain. | Q35877396 | ||
Ixodid and argasid tick species and west nile virus. | Q35880255 | ||
Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. | Q35979463 | ||
Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation | Q36240567 | ||
West Nile virus activity in Latin America and the Caribbean | Q36427477 | ||
P433 | issue | 8 | |
P921 | main subject | West Nile virus | Q158856 |
emerging pathogen | Q108429945 | ||
P304 | page(s) | 571-586 | |
P577 | publication date | 2016-05-20 | |
P1433 | published in | Infectious Diseases | Q7429961 |
P1476 | title | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen | |
P478 | volume | 48 |
Q39063232 | A Comprehensive Review of Common Bacterial, Parasitic and Viral Zoonoses at the Human-Animal Interface in Egypt |
Q91721434 | Acute encephalitis in immunocompetent adults |
Q38157380 | Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus |
Q45325120 | Biological and phylogenetic characteristics of West African lineages of West Nile virus |
Q54242196 | DETERMINING RAPTOR SPECIES AND TISSUE SENSITIVITY FOR IMPROVED WEST NILE VIRUS SURVEILLANCE. |
Q50532061 | Dynamics of tissue-specific CD8+ T cell responses during West Nile virus infection. |
Q30145555 | Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk |
Q93189786 | Equine viral encephalitis: prevalence, impact, and management strategies |
Q92150427 | Evidence for West Nile Virus and Usutu Virus Infections in Wild and Resident Birds in Germany, 2017 and 2018 |
Q54225952 | Experimental evaluation of infection, dissemination, and transmission rates for two West Nile virus strains in European Aedes japonicus under a fluctuating temperature regime. |
Q90468197 | Influence of herd immunity in the cyclical nature of arboviruses |
Q59137481 | Innate Immune Response of Primary Human Keratinocytes to West Nile Virus Infection and Its Modulation by Mosquito Saliva |
Q57279242 | Neglected vector-borne bacterial diseases and arboviruses in the Mediterranean area |
Q90479741 | Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus |
Q58554005 | Opsoclonus-Myoclonus Syndrome Associated With West-Nile Virus Infection: Case Report and Review of the Literature |
Q90521602 | Serological Evidence of West Nile and Usutu Viruses Circulation in Domestic and Wild Birds in Wetlands of Mali and Madagascar in 2008 |
Q61803658 | West Nile Virus Infection in Travelers Returning to United Kingdom from South Africa |
Q47549685 | West Nile Virus and Usutu Virus Monitoring of Wild Birds in Germany |
Search more.